Definitive Contract 00266200309D266030060

This is a definitive cost no fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the J. David Gladstone Institutes, a non-profit biomedical research organization located in San Francisco, California. The contract, valued at $7,323,791, is for AIDS research (basic) with a period of performance through November 30, 2006. The contract does not have a set-aside designation. The J. David Gladstone...

This is a $12,436,225.00 Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to BBI Biotech Research Laboratories Incorporated on June 30, 1998 for AIDS research (basic). The contract has an ultimate completion date of December 31, 2007 and was not set aside for any special designation. As NIAID is the research arm of the National Institutes of Health focused on infectious diseases, this contract is likely...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

The U.S. Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,150.00 cost-plus-fixed-fee delivery order contract to Southern Research Institute for assay development and validation to identify and evaluate the efficacy of anti-HIV therapeutics and topical microbicides. This contract is part of the agency's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. Southern...

This federal contract, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases, tasks Southern Research Institute with testing interventional agents in confirmatory and specialized assays to identify and characterize agents with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of HIV infection. The contract, which has a potential value of $174,999.00, does not have a set-aside designation and was...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the non-profit Research Triangle Institute (RTI International) for AIDS research. The contract is a definitive, cost-plus-fixed-fee contract with a ceiling value of $1,763,241.00 and a period of performance ending on June 30, 2007. The contract was not set aside and was competitively awarded. RTI International is an experienced federal contractor, holding various...

This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery, indefinite-quantity (IDIQ) contract. The $672,211.75 cost-plus-fixed-fee contract requires ABL to provide expertise in ethnographic research to enhance study drug adherence and uptake in human...

This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The $99,998.00 contract requires Southern Research to acquire and store chemical compound libraries, and conduct high-throughput screening to identify and characterize at least one agent that can block HIV...

This federal contract award, valued at $168,375.36, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract, which is part of NIAID's Preclinical Development Services for AIDS Therapeutics program, is a delivery order for a pharmacokinetic (PK) study in mice using three antiretroviral agents: SN38-Lactam, 05-9A, and 02-16....